12/18
10:52 am
anip
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
12/15
01:21 pm
anip
Gastroparesis Drugs Market size to increase by USD 1.42 Billion between 2023 to 2028, Market Segmentation by Drug Class, Disease Type, Geography, Technavio [Yahoo! Finance]
Low
Report
Gastroparesis Drugs Market size to increase by USD 1.42 Billion between 2023 to 2028, Market Segmentation by Drug Class, Disease Type, Geography, Technavio [Yahoo! Finance]
12/12
07:05 am
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
12/11
08:01 am
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $80.00 price target on the stock.
Low
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $80.00 price target on the stock.
12/2
03:48 pm
anip
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
11/27
03:15 pm
anip
Here's Why Retaining Cigna Stock is a Smart Move for Investors Now [Yahoo! Finance]
Low
Report
Here's Why Retaining Cigna Stock is a Smart Move for Investors Now [Yahoo! Finance]
11/26
04:30 pm
anip
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
Low
Report
ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
11/26
12:03 pm
anip
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect? [Yahoo! Finance]
Low
Report
Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect? [Yahoo! Finance]
11/14
11:31 am
anip
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? [Yahoo! Finance]
Low
Report
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? [Yahoo! Finance]
11/11
10:22 am
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.
Medium
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $94.00 price target on the stock.
11/9
04:11 am
anip
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
11/8
11:57 am
anip
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
11/8
07:08 am
anip
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance [Yahoo! Finance]
Medium
Report
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance [Yahoo! Finance]
11/8
06:50 am
anip
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
Medium
Report
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
11/7
07:18 am
anip
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
11/4
04:45 pm
anip
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November [Yahoo! Finance]
11/4
04:30 pm
anip
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
Low
Report
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
10/30
05:00 pm
anip
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET
Low
Report
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET
10/25
06:50 am
anip
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
Low
Report
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%
10/24
07:04 am
anip
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
10/24
06:50 am
anip
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
Low
Report
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
10/22
01:39 pm
anip
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Truist Financial Co. from $60.00 to $62.00. They now have a "hold" rating on the stock.
Low
Report
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) had its price target raised by analysts at Truist Financial Co. from $60.00 to $62.00. They now have a "hold" rating on the stock.
10/21
11:35 am
anip
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
Low
Report
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
10/17
01:23 pm
anip
GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review [Yahoo! Finance]
Low
Report
GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review [Yahoo! Finance]
10/17
07:32 am
anip
ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? [Yahoo! Finance]